NCT04864782 2024-01-12
QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 2/3 Terminated
Qilu Pharmaceutical Co., Ltd.
EMD Serono
Boehringer Ingelheim
University Hospital Tuebingen
AIO-Studien-gGmbH
Peking University
Transgene
European Organisation for Research and Treatment of Cancer - EORTC